# CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

> **NCT03582072** · NA · COMPLETED · sponsor: **Public Health England** · enrollment: 4796 (actual)

## Conditions studied

- Prescribing, Off-Label

## Interventions

- **BEHAVIORAL:** letter from the CMO

## Key facts

- **NCT ID:** NCT03582072
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 4796 (ACTUAL)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582072, "CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03582072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*